ASSESS INHIBITION ACTIVITY OF 2 TEST ARTICLES (TA) FOR GENERAL EFFLUX AND UPTAKE TRANSPORTERS

Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
State: Maryland
Type of Government: Federal
FSC Category:
  • Q - Medical Services
NAICS Category:
  • 541380 - Testing Laboratories
Posted Date: Jun 8, 2023
Due Date: Jun 15, 2023
Solicitation No: 75N95023Q00357
Bid Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page
Follow
ASSESS INHIBITION ACTIVITY OF 2 TEST ARTICLES (TA) FOR GENERAL EFFLUX AND UPTAKE TRANSPORTERS
Active
Contract Opportunity
Notice ID
75N95023Q00357
Related Notice
75N95023Q00312
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH NCATS
Looking for contract opportunity help?

Procurement Technical Assistance Centers (PTACs) are an official government contracting resource for small businesses. Find your local PTAC (opens in new window) for free government expertise related to contract opportunities.

General Information View Changes
  • Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
  • All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Updated Published Date: Jun 08, 2023 02:15 pm EDT
  • Original Published Date: May 30, 2023 02:49 pm EDT
  • Updated Date Offers Due: Jun 15, 2023 01:00 pm EDT
  • Original Date Offers Due: Jun 08, 2023 03:00 pm EDT
  • Inactive Policy: 15 days after date offers due
  • Updated Inactive Date: Jun 30, 2023
  • Original Inactive Date: Jun 23, 2023
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: Q301 - MEDICAL- LABORATORY TESTING
  • NAICS Code:
    • 541380 - Testing Laboratories and Services
  • Place of Performance:
    Bethesda , MD 20892
    USA
Description View Changes

AMMENDMENT 1 - Dated 06/08/2023



The due date for quotes is hereby extended to Thursday June 15, 2023 @ 1:00 PM EST.



ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED.





COMPETITIVE



COMBINED SYNOPSIS / SOLICITATION



Title: Assess inhibition activity of 2 test articles (TA) for general Efflux and Uptake Transporters



(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.



(ii) The solicitation number is 75N95023Q00357 and the solicitation is issued as a request for quotation (RFQ).



This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.



(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2023-02 with effective date March 16, 2023.



(iv) The associated NAICS code 541380 and the small business size standard $19M. This requirement is not set-aside for small business concerns.



DESCRIPTION



(v) The National Institutes of Health (NIH) is the nation’s leading medical research agency and the primary Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, conducting, supporting and making medical discoveries that improve people’s health and save lives.



The National Center for Advancing Translational Sciences (NCATS) is a part of the National Institutes of Health (NIH), which mission it is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.



To support drug development for Mitragynine and its major metabolite 7-hydroxymitragynine, the inhibition and substrate potential of the test article for major human transporters needs to be assessed



(vi) The purpose of this requisition is to assess inhibition activity and substrate potential of 2 test articles (TA) for each human transporter individually, using study designs in compliance with FDA recommendations., as per the attached STATEMENT OF WORK.



(vii) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated the period of performance to be anJune 30, 2023 – October 29, 2023. a final deliverable is final report approved by NCATS must be submitted prior to pinvoicing.



PROVISIONS, CLAUSES, AND OTHER TERMS AND CONDITIONS

(vii) The provision at FAR clause 52.212-1, Instructions to Offerors – Commercial Items (Tailored), applies to this acquisition and is attached in full text.



(viii) The Government will perform a comparative evaluation of responses in accordance with FAR 13.106-2(b)(3) and award a purchase order from this solicitation to the responsible offeror whose response meets the solicitation’s requirements and, as a whole, will be most advantageous to the Government, price and other factors considered. The evaluation will compare: Technical Capability of the service to meet the Government requirement, Price, and Past Performance as defined under FAR 13.106-2(b)(3). If only one quotation is received it will be evaluated on the preceding.

(ix) Offerors are to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with offers.



(x) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html

(End of provision)



The following provisions apply to this acquisition and are incorporated by reference:



FAR 52.204-7, System for Award Management (Oct 2018)



FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020)



FAR 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021)



FAR 52.204-26, Covered Telecommunications Equipment or Services-Representation (Oct 2020)



The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses:



https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html



(End of clause)



The following clauses apply to this acquisition and are incorporated by reference:

FAR 52.204-13, System for Award Management Maintenance (Oct 2018)

FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020)



FAR 52.204-21, Basic Safeguarding of Covered Contractor Information Systems (Nov 2021)



FAR 52.227-14, Rights in Data-General (May 2014). Pursuant to paragraph (d), the Contractor may not assert copyright, make use of, release to others, reproduce, distribute, or publish any data first produced or specifically used by the Contractor in the performance of this contract without prior approval of the contracting officer.



HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015)



HHSAR 352.223-70, Safety and Health (December 18, 2015)



NIH Invoice and Payment Provisions



The following provisions and clauses apply to this acquisition and are attached in full text:



(xi) The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services, applies to this acquisition and an addendum is attached in full text.



(xii) The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition and is attached in full text.

SUBMISSION INSTRUCTIONS



(xiii) Responses to this solicitation must include clear and convincing evidence of the offeror’s capability of providing the service. The quote must be for a firm-fixed-price total amount inclusive of all costs and fees.

The Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.



All responses must be received by 03:00 PM, Eastern Time on June 8, 2023, and reference Solicitation Number 75N95023Q00357 . Responses must be submitted by email to the Contract Specialist at claudia.ventola@nih.gov.



(xiv) The name and telephone number of the individual to contact for information regarding the solicitation:

Claudia Ventola, Contract Specialist, 301-496-0870, claudia.ventola@nih.gov.





ATTACHMENTS




  1. Statement of Work

  2. FAR 52.212-4 Addendum

  3. FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders–Commercial Items (Mar 2023)

  4. Invoice and Payment Provisions






Attachments/Links
Contact Information View Changes
Contracting Office Address
  • 6701 DEMOCRACY BLVD
  • BETHESDA , MD 20892
  • USA
Primary Point of Contact
Secondary Point of Contact


History

Related Document

May 30, 2023[Combined Synopsis/Solicitation (Original)] ASSESS INHIBITION ACTIVITY OF 2 TEST ARTICLES (TA) FOR GENERAL EFFLUX AND UPTAKE TRANSPORTERS

Sign-up for a Free Trial, Government Bid Alerts

With Free Trial, you can:

You will have a full access to bids, website, and receive daily bid report via email and web.

Try One Week FREE Now

See Also

Follow PAD Medical Coders and Transcription Services Active Contract Opportunity Notice ID HT001424R0004

Federal Agency

Bid Due: 11/17/2024

Login JavaScript enabled browser required. Form Details (Abstract): RFQ 47951 Status Active Abstract

Washington Suburban Sanitary Commission

Bid Due: 12/01/2024

Editing column ID Title Status Due / Close Date Publish Date Main Category

State Government of Maryland

Bid Due: 5/08/2024

Editing column ID Title Status Due / Close Date Publish Date Main Category

State Government of Maryland

Bid Due: 4/17/2024